2023 annual financial data
CG Oncology 2023 Operating margin
CG Oncology 2023 operating margin with verified reported values.
Direct answer
Operating margin was -27,180.88%.
Operating income was -55,449,000 USD and net income was -48,607,000 USD.
Operating cash flow was -45,679,000 USD.
Get free CG Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 204,000 USD
- Operating income
- -55,449,000 USD
- Net income
- -48,607,000 USD
- Operating cash flow
- -45,679,000 USD